Trial Condition(s):

Pulmonary hypertension, Pulmonary Stenosis

Adalat drops and Adalat retard 10 mg tablets in children with pulmonary hypertension and with peripheral pulmonary stenosis

Bayer Identifier:

Trial_1555

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

February1990

December1992

Phase

Could I receive a placebo?

Products

Adalat Retard (Nifedipine, BAYA1040)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Pulmonary hypertension, Pulmonary Stenosis

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

0 Months

15 Months

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information